Montana Biotech

Sorry, we couldn't find any posts. Please try a different search.

SpeciGen’s Bio-Nanotechnology Featured in Cover Article in Science

Montana State University (MSU) scientists, and SpeciGen Inc.’s scientific co-founders, Drs. Mark Young and Trevor Douglas authored the cover article “Viruses: Making Friends With Old Foes” in the May 12th edition of the journal Science .

New Montana Biotechnology Company, SpeciGen Launched, Lonnie Bookbinder Selected as CEO

"SpeciGen uses patented, new and unique drug delivery vehicles to create and develop products for the diagnostic imaging and therapeutic marketplaces. Investing in SpeciGen is a way to help technology developed in Montana, stay in Montana and will allow SpeciGen to contribute to the state’s fledgling biomedical industry."

Renowned Stem Cell Researcher, Dr. Irving Weissman “Stem Cells: Science, Medicine and Politics”, 4/10, Missoula, MT

Weissman, an advocate for stem cell science, is director of the Institute of Cancer and Stem Cell Biology and Medicine at Stanford University and a professor in the school’s departments of developmental biology, pathology and biology.

Non-profit aids Arizona bioscience. Bolstering research, attracting firms are goals

Science Foundation Arizona is being created to attract private and public funding for biotech and biosciences, distribute the funds to key research efforts and lure new companies.

Sixty Pacific Northwest Life Science Companies to Present at Invest Northwest(C) 2006

Biotechnology, Medical Device and Bioinformatics Firms From Washington, British Columbia, Oregon, Alberta and Montana Selected to Present March 21-22 in Seattle

Fort Collins startup captures fast-pitch award

The emerging companies highlighted at the 2005 BioWest conference that started Tuesday:

Biotech companies pitch their potential to investors – BioWest 2005., a two-day event that opens Tuesday, showcases firms in the Rocky Mountain region.

Most of the participants hail from Colorado, with others from Utah, Wyoming and Montana.

LigoCyte Pharmaceuticals of Bozeman, Montana Receives $4.6M NIH Biodefense Challenge Grant for Intranasal Anthrax Vaccine

"Securing this level of a competitive NIH award validates our anthrax vaccine approach and allows us to quickly move forward in our preclinical development,"

Missoula biotech startup, Rocky Mountain Biologicals Inc. looks to go global

The new business will increase the size of Missoula’s budding biotech industry, and that bodes well for the area economy.

University of Montana to Break Ground on New Biomedical Research Building Addition

"It is remarkable, I think, that of the top 20 institutions receiving NIH grants and contracts in 2004, UM is the only one located in a state without a medical school," said Dean David Forbes. "Clearly, our scientists are a serious national — even international — force in the investigation of health issues."